Fierce Biotech Mix Logo.png Fierce Biotech Mix Logo.png
Webinar

From Fragmented Data to Connected Decisions in Clinical Development

Available on-demand
60 Minutes

Clinical development teams have more data, technology, and AI than ever, yet critical decisions across study design, country allocation, feasibility, site selection, startup, and execution often remain disconnected. 

Join us to examine what it takes to move beyond fragmented data, isolated tools, and AI pilots toward a more connected approach to clinical development. The discussion will feature insights from industry leader Novo on how connected data, AI, real-time site feedback, and human expertise can improve decision-making and create greater continuity across the trial lifecycle. 

You’ll learn: 

  • Why fragmented data and disconnected workflows continue to challenge clinical development decision-making 
  • How connected data and AI can improve visibility and preserve context from study planning through execution 
  • Lessons from Novo on what enterprise-wide transformation requires beyond technology, including adoption, governance, and change management 
  • How clinical development teams can build a foundation for more timely, informed, and consistent decisions 

Speakers

Guillaume Carbonneau

Guillaume Carbonneau

Register here to watch on-demand!